Jun, Yang,
Wang, Minxiu,
Xu, Yulan,
Liao, Jing,
Li, Xiang,
Zhou, Ying,
Dai, Jintian,
Li, Xiaobo,
Chen, Pan,
Chen, Gaozhi,
Cho, Won-Jea,
Chattipakorn, Nipon,
Samorodov, A.V,
Pavlov, V.N,
Wang, Yi,
Liang, Guang,
Tang, Qidong (2023) pharmacokinetic properties with T2 value of 11.8
h and F value of 36.3%. Therefore, this study has identified a
Kazantseva, A.,
Enikeeva, R.,
Takhirova, Z.,
Davydova, Y.,
Mustafin, R.,
Malykh, S.,
Karunas, A.,
Kanapin, A.,
Khusnutdinova, E. (2023) ) and remaining neurological complications (OR = 2.12, 95% CI 1.10–4.35 for SLC6A20), while NR1
H2 (OR = 2.99, 95